Aradigm Corporation and Grifols S.A. Company Profile

13:49 EDT 24th March 2018 | BioPortfolio

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. Aradigm has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and prevention of respiratory and other diseases in tobacco smokers through smoking cessation.

News Articles [153 Associated News Articles listed on BioPortfolio]

FDA panel rejects Aradigm/Grifols’ inhaled antibiotic

Further evidence is required to warrant approval according to the US regulator

FDA Nixes Aradigm’s Inhaled Antibiotic, Asks for New Clinical Trial

Aradigm’s attempt to commercialize an inhalable version of a generic antibiotic as a treatment for chronic lung infections has stalled with the FDA’s rejection of the company’s drug approval app...

Aradigm seeks EU nod for noncystic fibrosis lung infection drug

A marketing application was filed by Aradigm in Europe for Linhaliq, or ciprofloxacin for inhalation, which is being develope -More- 

In The Spotlight: Aradigm Corp

Shares of Aradigm Corp. (ARDM) have returned nearly 96% over the past one month as the Company gears up for the big event on January 11, 2018, when a panel of outside experts convened by the FDA will ...

Another FDA blow for Aradigm sees shares slump nearly 40%

US specialty drug firm Aradigm saw its shares plummet at much as 39% to $1.36 in morning trading on Monday,…

US FDA serves Aradigm CRL, Phase III data wanted

The US FDA has recommended Aradigm Corporation conduct an additional Phase III trial before resubmitting a new drug application for Linhaliq.

Aradigm (ARDM) Stock Rating Lowered by Ladenburg Thalmann Financial Services

ARDM has been the topic of several other reports. Zacks Investment Research downgraded shares of Aradigm from a "buy" rating to a "hold" rating in a research note on Wednesday, September 27th.

ARDM NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Aradigm ...

To join the Aradigm class action, go to call Phillip Kim, Esq.or Daniel Sadeh, Esq.toll-free at 866-767-3653 or email pkim@rosenlegal.comor Read more...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis.

GamaSTAN S/D (Grifols Therapeutics, Inc., Research Triangle Park, North Carolina) is a sterile, preservative-free solution of immune globulin (IG) for intramuscular administration and is used for prop...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

The purpose of this study is to evaluate the safety and hemostasis effectiveness of human plasma-derived fibrin sealant Grifols (FS Grifols) in peripheral vascular surgery.

Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Subjects

This is a prospective, randomized, active-controlled, single-blind, parallel group clinical trial to evaluate the safety and efficacy of FS Grifols as an adjunct to hemostasis during surge...

Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Open Surgeries

This purpose of this clinical trial is to study the safety and efficacy of Topical Thrombin (Human) Grifols as an add-on treatment to help stop bleeding during vascular, parenchymous tissu...

Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura

The purpose of this study is to determine whether IGIV3I 10% Grifols is effective in the treatment of immune thrombocytopenic purpura.

IGIV Study for Chronic ITP Patients Ages 3-70

Idiopathic (immune) thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by platelet destruction and thrombocytopenia (peripheral blood platelet count < 150 x 10(9)/L). ...

Companies [181 Associated Companies listed on BioPortfolio]

Aradigm Corporation and Grifols S.A.

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of sever...

Grifols Biomat USA

Grifols Biomat USA is part of a large a network of plasma collection centers owned and operated by Grifols, a global healthcare company headquartered in Barcelona, Spain. Today, Grifols' plasma t...


Grifols has been present in the field of healthcare since 1940 creating innovative products and services based on the values of ethics and responsibility. Over the decades, Grifols has contributed sig...

Grifols S.A.

Grifols S.A. is a Spain-based company in the healthcare sector involved in the research, development, manufacturing and marketing of plasma therapies, IV therapy solutions, enteral and parenteral nutr...

Grifols, Inc.

Currently, we supply plasma products, diagnostic reagents, automated analyzers and dosing machines.In 1998, Grifols established a joint venture with a US diagnostic company, Quest International. Then,...

More Information about "Aradigm Corporation and Grifols S.A." on BioPortfolio

We have published hundreds of Aradigm Corporation and Grifols S.A. news stories on BioPortfolio along with dozens of Aradigm Corporation and Grifols S.A. Clinical Trials and PubMed Articles about Aradigm Corporation and Grifols S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aradigm Corporation and Grifols S.A. Companies in our database. You can also find out about relevant Aradigm Corporation and Grifols S.A. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Corporate Database Quicklinks

Searches Linking to this Company Record